Correlation Between Cardio Diagnostics and Conduit Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Conduit Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Conduit Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and Conduit Pharmaceuticals, you can compare the effects of market volatilities on Cardio Diagnostics and Conduit Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Conduit Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Conduit Pharmaceuticals.
Diversification Opportunities for Cardio Diagnostics and Conduit Pharmaceuticals
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cardio and Conduit is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Conduit Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Conduit Pharmaceuticals and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Conduit Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Conduit Pharmaceuticals has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Conduit Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cardio Diagnostics and Conduit Pharmaceuticals
Given the investment horizon of 90 days Cardio Diagnostics Holdings is expected to under-perform the Conduit Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Cardio Diagnostics Holdings is 4.01 times less risky than Conduit Pharmaceuticals. The stock trades about -0.03 of its potential returns per unit of risk. The Conduit Pharmaceuticals is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 5.35 in Conduit Pharmaceuticals on September 5, 2024 and sell it today you would lose (3.35) from holding Conduit Pharmaceuticals or give up 62.62% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 56.05% |
| Values | Daily Returns |
Cardio Diagnostics Holdings vs. Conduit Pharmaceuticals
Performance |
| Timeline |
| Cardio Diagnostics |
| Conduit Pharmaceuticals |
Cardio Diagnostics and Conduit Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cardio Diagnostics and Conduit Pharmaceuticals
The main advantage of trading using opposite Cardio Diagnostics and Conduit Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Conduit Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Conduit Pharmaceuticals will offset losses from the drop in Conduit Pharmaceuticals' long position.| Cardio Diagnostics vs. Immix Biopharma | Cardio Diagnostics vs. Cns Pharmaceuticals | Cardio Diagnostics vs. Sonnet Biotherapeutics Holdings | Cardio Diagnostics vs. Zura Bio Limited |
| Conduit Pharmaceuticals vs. Candel Therapeutics | Conduit Pharmaceuticals vs. Cingulate Warrants | Conduit Pharmaceuticals vs. Unicycive Therapeutics | Conduit Pharmaceuticals vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |